Research Paper Volume 11, Issue 6 pp 1716—1732

Figure 4. Survival comparison of the patient received different treatments in the high and low FPR subgroups and the dynamic change of FPR during the treatment. (a) Kaplan-Meier curve of OS within the patient received different treatment in low-FPR subgroup; (b) Kaplan-Meier curve of OS within the patient received different treatment in high-FPR subgroup; (c) dynamic change of FPR in left- and right-sided mCRC patients; (d) dynamic change of FPR of mCRC patient undergoing chemotherapy or palliative resection Abbreviation within in Panels 4a-b: A: radiochemotherapy; B: palliative resection plus radiochemotherapy; C: bevacizumab plus radiochemotherapay. Abbreviation within in Panels 4c-d: 1: the diagnostic time; 2: one month after the first treatment; 3: regular examination without disease progression; 4: one month before disease progression; 5: time of imaging confirmed progression; 6: within three months before death.